Loading…
Labcorp Holdings Inc. is projected to rise to $371.28 by 2027, a +18% move from its current price of $314.23. LH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $309.47 | $314.24 | $319.07 | 0.00% |
| Aug 1 | $307.52 | $314.24 | $321.11 | 0.00% |
| Aug 2 | $306.04 | $314.25 | $322.68 | +0.01% |
| Aug 3 | $304.79 | $314.25 | $324.01 | +0.01% |
| Aug 4 | $303.70 | $314.26 | $325.18 | +0.01% |
| Aug 5 | $302.71 | $314.26 | $326.25 | +0.01% |
| Aug 6 | $301.81 | $314.27 | $327.24 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $301.81 | $314.27 | $327.24 | +0.01% |
| Week 2 | $296.83 | $314.30 | $332.80 | +0.02% |
| Week 3 | $293.08 | $314.34 | $337.15 | +0.04% |
| Week 4 | $289.95 | $314.38 | $340.86 | +0.05% |
| Week 5 | $287.23 | $314.41 | $344.17 | +0.06% |
| Week 6 | $284.80 | $314.45 | $347.19 | +0.07% |
| Week 7 | $282.58 | $314.49 | $350.00 | +0.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Labcorp Holdings Inc. provides laboratory services and operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers tests such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.
It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Labcorp Holdings Inc. (LH) is a healthcare services company with a current price of $301.17 and a market cap of $24.7B, ranking 480. The stock currently shows a bullish technical stance, supported by a RSI14 reading of 70 and moving averages above the price, with a SMA50 of $268.60 and a SMA200 of $267.49.
The stock features a near-term resistance at $301.17 and a support at $254.43, with a 30-day trading range between $273.92 and $331.13. Annualized volatility sits at 30%. The long-term outlook is constructive, with a year-by-year forecast showing a rising average price from 2026 through 2050 and progressively higher ROI figures.
A major floor 25.4% below — a decisive break under it would weaken the trend.
The nearest floor, 19.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.7% above — clearing it would confirm fresh momentum.
Key LH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $296.93 | Buy | $299.77 | Buy |
| MA 10 | $288.28 | Buy | $292.26 | Buy |
| MA 20 | $284.32 | Buy | $284.99 | Buy |
| MA 50 | $270.65 | Buy | $275.58 | Buy |
| MA 100 | $267.80 | Buy | $271.09 | Buy |
| MA 200 | $267.76 | Buy | $267.20 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 79.51 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 290.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 2.73 | Buy |
| ROC (12) | 13.52 | Buy |
| Bollinger %B (20,2) | 1.27 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 20.50 | Buy |
| Ultimate (7,14,28) | 85.33 | Sell |
| Momentum (10) | 38.55 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 306.90 | Buy |
| ADX (14) | 25.67 | Buy |
| ATR (14) | 4.24 | Info |
The 30-day technical picture is bullish, with a sentiment leaning positive and RSI14 at 70 indicating strong momentum. Key short-term indicators show the price trading above the SMA50 of $268.60 and the SMA200 of $267.49, suggesting upside pressure may persist. The stock’s immediate range spans from a low of $273.92 to a high of $331.13, with a nearby resistance at $301.17 and support at $254.43.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $250.39 | $314.23 | $380.56 | 0% | Neutral | |
| $304.39 | $371.28 | $473.26 | +18% | Neutral | |
| $328.85 | $408.75 | $535.31 | +30% | Bullish | |
| $391.38 | $494.02 | $660.89 | +57% | Bullish | |
| $477.85 | $611.37 | $832.71 | +95% | Bullish | |
| $526.25 | $681.55 | $943.06 | +117% | Bullish | |
| $583.73 | $764.56 | $1,073.04 | +143% | Bullish | |
| $610.00 | $807.41 | $1,147.91 | +157% | Bullish | |
| $640.40 | $856.10 | $1,231.73 | +172% | Bullish | |
| $741.40 | $1,000.52 | $1,455.59 | +218% | Bullish | |
| $1,114.10 | $1,568.24 | $2,391.21 | +399% | Bullish | |
| $2,207.86 | $3,333.37 | $5,448.80 | +961% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $250.39 | $314.23 | $366.93 | +0.00% |
| August 2026 | $266.54 | $310.93 | $369.75 | -1.05% |
| September 2026 | $268.27 | $314.71 | $377.69 | +1.22% |
| October 2026 | $270.85 | $319.17 | $385.84 | +1.42% |
| November 2026 | $265.34 | $313.85 | $381.68 | -1.67% |
| December 2026 | $262.24 | $311.24 | $380.56 | -0.83% |
Click any year to see its month-by-month LH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LH price prediction for 2026 points to an average of $314.23 (low $250.39, high $380.56) — a potential gain of 0% on today's $314.23. A consolidation phase looks the most probable path here.
In 2027, LH is projected to trade between $304.39 and $473.26, averaging $371.28 — a potential gain of +18% from today's $314.23. That is up +18% on the projected 2026 average. Price action looks broadly range-bound.
Labcorp Holdings Inc.'s 2028 outlook centres on $408.75, within a $328.85 to $535.31 range. That is up +10% on the projected 2027 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, LH could reach as high as $660.89, with a base case around $494.02 and support toward $391.38 — roughly +57% from $314.23. Momentum favours further upside here.
Expect LH to range from $477.85 to $832.71 through 2030. The $611.37 average target implies a +95% move from current prices. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The LH price prediction for 2031 points to an average of $681.55 (low $526.25, high $943.06) — a potential gain of +117% on today's $314.23. Momentum favours further upside here.
In 2032, LH is projected to trade between $583.73 and $1,073.04, averaging $764.56 — a potential gain of +143% from today's $314.23. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Labcorp Holdings Inc.'s 2033 outlook centres on $807.41, within a $610.00 to $1,147.91 range. That is up +6% on the projected 2032 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2034, LH could reach as high as $1,231.73, with a base case around $856.10 and support toward $640.40 — roughly +172% from $314.23. Buyers look set to stay in control over this stretch.
Expect LH to range from $741.40 to $1,455.59 through 2035. The $1,000.52 average target implies a +218% move from current prices. That is up +17% on the projected 2034 average. Momentum favours further upside here.
The LH price prediction for 2040 points to an average of $1,568.24 (low $1,114.10, high $2,391.21) — a potential gain of +399% on today's $314.23. Buyers look set to stay in control over this stretch.
In 2050, LH is projected to trade between $2,207.86 and $5,448.80, averaging $3,333.37 — a potential gain of +961% from today's $314.23. That is up +113% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LH today (≈ 3.182382 LH) could be worth
$10,608.05
+$9,608.05 (+961%) by 2050 · US Dollar
Based on the average projected LH price of $3,333.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LHwould be worth at today's price.
$1,000 invested in LH on Jul 28, 2025 (≈ 3.818543 LH) would be worth
$1,199.9
+$199.9 (+20.0%) today · 1.20× · US Dollar
Based on a LH entry price of $261.88 vs. today's $314.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $279.4 | $1,124.66 | +12.5% |
| 1 month ago | $279.58 | $1,123.94 | +12.4% |
| 3 months ago | $257.14 | $1,222.02 | +22.2% |
| 6 months ago | $269.81 | $1,164.63 | +16.5% |
| 1 year ago | $261.88 | $1,199.9 | +20.0% |
| All time (5.0y) ago | $255.68 | $1,229 | +22.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LH forecast.
Our base-case forecast reaches $630.00 around 2031.
Implied market cap at $630.00: $51.66B
The multi-year forecast portrays a substantial upward trajectory. In 2026 the avg price is $301.17, with a min of $250.39 and a max of $363.07 and an ROI of 0, with a Neutral sentiment. By 2030, the avg rises to $558.59 and the max to $760.87, with an ROI of 85.5% and a bullish tone.
The forecast continues to grow, reaching an avg of $1,362.79 in 2040 with a 352.5% ROI, and $2,853.04 by 2050 with an 847.3% ROI, all under bullish sentiment. The path includes a sequence of higher averages year by year, reflecting an expanding valuation horizon. These figures are estimates of potential outcomes, not guarantees, and actual results depend on market conditions and company performance.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $558.59, with a min of $436.59 and a max of $760.87, and an ROI of 85.5% with a bullish sentiment.
The forecast shows a bullish trajectory from 2027 onward, with the avg price rising to $558.59 by 2030 and continuing higher to $2,853.04 by 2050, accompanied by ROIs of up to 847.3% and a long-term bullish sentiment (2026 is Neutral, 2027+ is Bullish).
Yes. The 2033 forecast max is $1,029.70, indicating a potential above-$1,000 level in 2033 according to the forecast.
Annualized volatility is 30%.
The 30-day range is $273.92 to $331.13.
Labcorp Holdings Inc. Community Discussion
0Share your Labcorp Holdings Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.